{"DataElement":{"publicId":"2950727","version":"1","preferredName":"New Malignant Neoplasm Lymphoproliferative Myelodysplastic/Myeloproliferative Diseases and Disorders Diagnosis Specify Text","preferredDefinition":"The free-text field to describe the new malignancy, myelodysplastic, myeloproliferative, or lymphoproliferative disorder.","longName":"NE_MN_LD_MM_DX_SP","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2587712","version":"1","preferredName":"New Malignant Neoplasm Lymphoproliferative Disorder Myelodysplastic/Myeloproliferative Disease Diseases and Disorders Diagnosis","preferredDefinition":"information related to the diagnosis, investigation, analysis and recognition of the presence and nature of a new, distinct tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues, disease, disorder characterized by proliferation of lymphocytes at various stages of differentiation, or category of clonal myeloid disorders that have both myelodysplastic and chronic myeloproliferative features at the time of initial presentation.","longName":"N_MAL_LYM_MYE_DZ_DX","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2587710","version":"1","preferredName":"New Malignant Neoplasm Lymphoproliferative Disorder Myelodysplastic/Myeloproliferative Disease Diseases and Disorders","preferredDefinition":"New; having no previous example or precedent or parallel.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:A disorder characterized by proliferation of lymphocytes at various stages of differentiation. Lymphoproliferative disorders can be neoplastic (clonal, as in lymphomas and leukemias) or reactive (polyclonal, as in infectious mononucleosis). --2004:A category of clonal myeloid disorders that have both myelodysplastic and chronic myeloproliferative features at the time of initial presentation.  (WHO, 2001) -- 2003:A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C25586:C9305:C9308:C27262:C299","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Lymphoproliferative Disorder","conceptCode":"C9308","definition":"A disorder characterized by proliferation of lymphocytes at various stages of differentiation. Lymphoproliferative disorders can be neoplastic (clonal, as in lymphomas and leukemias) or reactive (polyclonal, as in infectious mononucleosis).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Myelodysplastic/Myeloproliferative Neoplasm","conceptCode":"C27262","definition":"A category of clonal hematopoietic disorders that have both myelodysplastic and myeloproliferative features at the time of initial presentation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"272E80F5-85B1-6722-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-16","modifiedBy":"ONEDATA","dateModified":"2007-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2239981","version":"1","preferredName":"Diagnosis","preferredDefinition":"The process of identifying a disease by the signs and symptoms.","longName":"C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-1C71-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-26","modifiedBy":"ONEDATA","dateModified":"2005-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"272E80F5-85BF-6722-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-01-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2799057","version":"1","preferredName":"Specify Text","preferredDefinition":"Be specific about something; define clearly._Text; the words of something written.","longName":"SPC_TXT","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2799056","version":"1","preferredName":"Specify Text","preferredDefinition":"Specify; be specific about something; define clearly.:Text; the words of something written.","longName":"C25685:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FE321-D89B-66BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-11","modifiedBy":"ONEDATA","dateModified":"2008-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FE321-D8AC-66BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-11","modifiedBy":"MALUMK","dateModified":"2021-01-19","changeDescription":"03/17/10-Added CSI for F2000-CJL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"}]},{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964902","version":"1","longName":"2100r1: 100 Days Post-HSCT Data","context":"NHLBI"},{"publicId":"3160397","version":"1","longName":"2455: Selective Post-Transplant Essential Data","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685478","version":"1","longName":"Testing Set – Moderately Different","context":"NCIP"}]}],"AlternateNames":[{"name":"new_malig_othr_leuk_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"new_malig_othr_skin_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"new_malig_othr_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"Alliance","type":"USED_BY","context":"Alliance"},{"name":"NE_MN_LD_MM_DX_SP","type":"USED_BY","context":"Alliance"},{"name":"CCR","type":"USED_BY","context":"CCR"},{"name":"TPST_NMM_new_malig_othr_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_NMM_new_malig_othr_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"CPST_NMM_new_malig_othr_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"NM_NMLM_new_malig_othr_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedDiagnosis:value","type":"HCT_BRIDG_5","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify the new malignancy, l","type":"Preferred Question Text","description":"Specify the new malignancy, lymphoproliferative or myeloproliferative disorder:","url":null,"context":"NHLBI"},{"name":"Specify leukemia:","type":"Alternate Question Text","description":"Specify leukemia:","url":null,"context":"NHLBI"},{"name":"Specify skin malignancy:","type":"Alternate Question Text","description":"Specify skin malignancy:","url":null,"context":"NHLBI"},{"name":"Specify other malignancy:","type":"Alternate Question Text","description":"Specify other malignancy:","url":null,"context":"NHLBI"},{"name":"CRF Text1","type":"Alternate Question Text","description":"If yes, specify","url":null,"context":"Alliance"},{"name":"Specify other new malignancy:","type":"Application Standard Question Text","description":"Specify other new malignancy:","url":null,"context":"NHLBI"},{"name":"Specify other new malignancy:","type":"Alternate Question Text","description":"Specify other new malignancy:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7559C96C-30CD-AE2B-E040-BB89AD437CD2","latestVersionIndicator":"Yes","beginDate":"2009-10-07","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-07","modifiedBy":"ALEYR","dateModified":"2019-04-13","changeDescription":". Added human readable def. System generated def displayed as alt def.  Also added ASQT/AQT for 2100r4/2450/4100. AK 1/5/16. 2/9/16mn-(no asqt. added asqt for 2450r4.); Added HCT_BRIDG5 alternate name - RR 2018-12-23","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}